Datavault AI and Wellgistics Health Launch $4B DelivMeds AI Venture to Revolutionize Healthcare Delivery

Datavault AI Inc. (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform that integrates AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery. The venture, formed through three concurrent transactions, carries an expected approximate asset value of $4 billion, subject to an independent fairness opinion. This move signals a significant step toward a national rollout of data-driven healthcare delivery and patient engagement solutions.

The transactions include an expanded PharmacyChain(TM) license, the acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. By combining these assets, DelivMeds AI aims to leverage Datavault’s expertise in AI-driven data experiences and monetization within the Web 3.0 environment, alongside Wellgistics’ healthcare distribution network. The platform is designed to optimize pharmacy operations, enhance patient engagement, and ensure secure, verifiable transactions through blockchain and biometrics.

This development is important because it addresses critical inefficiencies in healthcare delivery, particularly in pharmacy management and patient data security. The integration of AI and blockchain can reduce costs, improve medication adherence, and streamline supply chains. For investors, the venture represents a high-value opportunity in the growing healthcare AI market, with the $4 billion valuation underscoring the potential scale of the initiative.

Datavault AI, headquartered in Philadelphia, PA, specializes in AI-driven data solutions across multiple industries, including healthcare. Its Data Science division leverages Web 3.0 and high-performance computing for data perception, valuation, and monetization, while its Acoustic Sciences division holds patented technologies in spatial audio. The company’s Information Data Exchange(R) enables Digital Twins and secure licensing of name, image, and likeness through immutable metadata. For more details on the press release, visit https://ibn.fm/yIVh9.

The partnership with Wellgistics Health, a company focused on healthcare logistics, positions DelivMeds AI to scale rapidly. The venture’s focus on direct-to-consumer delivery aligns with post-pandemic trends favoring home healthcare and digital health solutions. By combining AI optimization with blockchain transparency, DelivMeds AI could set new standards for patient data privacy and operational efficiency.

As Datavault AI continues to expand its footprint in healthcare, this venture highlights the convergence of AI, blockchain, and biometrics in transforming traditional industries. The success of DelivMeds AI could pave the way for similar integrations across other sectors, reinforcing Datavault’s role as a leader in data-driven innovation. For ongoing updates about Datavault AI, visit the company’s newsroom at https://ibn.fm/DVLT.